Sorin Group - Cardiac Rythm Management

Paris, France - December 2, 2009

Your Name Here — Wed, 02 Dec 2009 15:02:00 +0100

Sorin Group Announces the First Inclusion in the Clepsydra Clinical Study in the USA.

Milan, Italy and Paris, France - November 30, 2009

Your Name Here — Mon, 30 Nov 2009 14:54:00 +0100

Orange Business Services and Sorin Group Awarded Best Change-Maker for Innovations in Remote Health Monitoring and Telemedicine.

Toronto, ON, Canada - July 7, 2009

Your Name Here — Wed, 08 Jul 2009 12:44:00 +0200

Sorin Group Announced World's Smallest Implantable Dual Chamber Pacemaker, REPLY™, Now Available in Canada.

Tokyo, Japan - July 3, 2009

Your Name Here — Sat, 04 Jul 2009 12:07:00 +0200

Sorin Group announced today regulatory approval and first implants of new-platform, FACIL™ and REPLY™ pacemakers in Japan.

Paris, France - June 24, 2009

Your Name Here — Thu, 25 Jun 2009 10:32:00 +0200

Sorin Group announced today the commercial market release and first implant of its new generation PARADYM™ DR 8550 dual chamber implantable cardioverter-defibrillator (ICD).

Denver, CO, USA - October 22, 2007

Your Name Here — Tue, 23 Oct 2007 10:36:00 +0200

ELA Medical, Inc, a Sorin Group company, announced today the first U.S. implant in the Investigational Trial of the OVATIO™ CRT, Cardiac Resynchronization Therapy Defibrillator, Model 6750.

Denver, Colorado, USA - December 3, 2007

Your Name Here — Wed, 05 Dec 2007 10:19:00 +0100

ELA Medical, Inc., a Sorin Group company, announced the first U.S. enrollment in the OPTION study (Optimal Anti-tachycardia Therapy in ICD Patients without Pacing Indications).

Denver, Colorado, USA - March 7, 2008

Your Name Here — Fri, 07 Mar 2008 15:54:00 +0100

ELA Medical Inc., a Sorin Group company, announces the U.S. Food and Drug Administration’s approval to market ISOLINE, its latest generation of defibrillation leads.

Paris, France, June 17, 2010

Your Name Here — Thu, 17 Jun 2010 16:30:00 +0200

CLEAR study demonstrates that automatic optimization of CRT with SonR improves heart failure patient response rates.

Denver, Colorado, USA - May 15, 2008

Your Name Here — Fri, 16 May 2008 16:11:00 +0200

FDA approval of the world's smallest Cardiac Resynchronization Implantable Cardioverter Defibrillator: OVATIO™ CRT

Clarence, New York, USA - May 16, 2008

Your Name Here — Tue, 20 May 2008 10:08:00 +0200

Sorin Group and Greatbatch announce collaborative agreement to leverage Greatbatch’s MRI technology for Sorin Group CRM devices.

Paris, France - June 20, 2008

Your Name Here — Mon, 23 Jun 2008 16:28:00 +0200

Qualitative study presented at the CARDIOSTIM congress gives voice to Pacemaker, Defibrillator and CRT patients.

Denver, Colorado, USA - August 7th, 2008

Your Name Here — Tue, 12 Aug 2008 11:47:00 +0200

Sorin Group announced today the U.S. Food and Drug Administration’s (FDA) approval to market the REPLY family of dual and single chamber pacemakers.

Paris, France - November 26th, 2008

Your Name Here — Wed, 26 Nov 2008 17:22:00 +0100

Sorin Group announced today the commercial market release and first implant of PARADYM™ CRT 8750 cardiac resynchronization therapy defibrillator (CRT-D) and the new SITUS™ BW 28D left ventricle pacing lead and lead delivery system.

Tokyo, Japan - December 11th, 2008

Your Name Here — Thu, 11 Dec 2008 14:19:00 +0100

Sorin Group announced today the Japanese approval and the market release of ISOLINE, its latest generation of defibrillation leads.

Paris, France - March 18th, 2009

Your Name Here — Tue, 24 Mar 2009 08:45:00 +0100

Sorin Group and Orange to develop a remote monitoring solution for patients implanted with cardiac rhythm management (CRM) devices.

Paris, France - April 3rd, 2009

Your Name Here — Mon, 06 Apr 2009 10:00:00 +0200

Sorin Group announced today the European market release of the ESPRIT pacemaker family.

Milan, Italy, February 5, 2010

Your Name Here — Fri, 05 Feb 2010 18:32:00 +0100

Sorin Group Announces Market Release and First Implant of Next-Generation Cardiac Resynchronization Therapy Defibrillator.